Medicine and Dentistry
Tick Borne Encephalitis
100%
Apoplexy
27%
Brain Ischemia
23%
Tick Borne Encephalitis Virus
20%
Multiple Sclerosis
18%
Myasthenia gravis
18%
Medical Care
18%
Magnetic Resonance Imaging
18%
Headache
16%
Enzyme Linked Immunosorbent Assay
15%
Cerebral Hemorrhage
14%
Cross Sectional Study
14%
Tick Borne Encephalitis Vaccine
14%
Mild Cognitive Impairment
13%
Observational Study
12%
Clinical Feature
12%
Transient Ischemic Attack
12%
Epileptic Seizure
12%
Odds Ratio
11%
Central Nervous System
9%
Polyneuropathy
9%
Bulbar Palsy
8%
Outpatient
8%
Lyme Borreliosis
8%
Human Herpesvirus 7
8%
COVID-19
7%
Rituximab
7%
National Institutes of Health Stroke Scale
7%
Cognitive Defect
7%
Arm
7%
Tick-Borne Disease
6%
Patient with Epilepsy
6%
Tick Bite
6%
Computer Assisted Tomography
6%
Medical Record
6%
Alcoholic Polyneuropathy
6%
HLA-DRB1
6%
Ankylosing Spondylitis
6%
Fatality
6%
Perivascular Space
6%
Posterior Reversible Encephalopathy Syndrome
6%
ECG Abnormality
6%
Scleroderma
6%
Caprylic Acid
6%
Sequela
6%
Acute Intermittent Porphyria
6%
Brain Hematoma
6%
Troponin T
6%
Human Herpesvirus 6
6%
Dizziness
6%
Neuroscience
Cognitive Disorders
51%
Multiple Sclerosis
41%
Mild Cognitive Impairment
35%
Encephalitis
27%
Expanded Disability Status Scale
19%
Magnetic Resonance Imaging
18%
Blood Plasma
17%
Cerebrovascular Accident
16%
Montreal Cognitive Assessment
15%
Magnetic Resonance Imaging
13%
Brain Ischemia
12%
Headache
12%
Transient Ischemic Attack
12%
Parkinson's Disease
12%
Relapsing Remitting Multiple Sclerosis
9%
Neurofilament Light Chain
8%
Human Herpesvirus 7
8%
Rituximab
8%
Cerebral Hemorrhage
7%
Alzheimer's Disease
7%
Placebo
6%
ELISA
6%
Magnetic Resonance Imaging of Brain
6%
Cerebellar Cortex
6%
Severe Depression
6%
Brodmann Area
6%
Hamilton Rating Scale for Depression
6%
Fractional Anisotropy
6%
Teriflunomide
6%
Automutilation
6%
Ofatumumab
6%
Corpus Callosum
6%
Cerebellum
6%
Neuromyelitis Optica
6%
Tenecteplase
6%
Secondary Progressive Multiple Sclerosis
6%
Lyme Disease
6%
Randomized Controlled Trial
6%
QT Interval
6%
Left Ventricular Hypertrophy
6%
Human Herpesvirus 6
6%
Roseolovirus
6%
Amygdala
6%
Cognitive Tests
6%
SARS Coronavirus
6%
Human Leukocyte Antigen
6%
Receptor
6%
Diffusion Tensor Imaging
5%
Intravenous Immunoglobulin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
36%
Tick Borne Encephalitis
36%
Cerebrovascular Accident
24%
Multiple Sclerosis
24%
Transient Ischemic Attack
18%
Brain Hemorrhage
16%
Fibrinolytic Agent
12%
Myasthenia gravis
12%
Mortality Rate
9%
Human Herpesvirus 7
9%
Tick Borne Encephalitis Virus
8%
Placebo
8%
Tick Borne Encephalitis Vaccine
8%
Immunotherapy
8%
Enzyme-Linked Immunosorbent Assay
7%
Randomized Controlled Trial
6%
Atrial Fibrillation
6%
Human Immunoglobulin
6%
Idarucizumab
6%
Antithrombotic Therapy
6%
ECG Abnormality
6%
Sudden Death
6%
Observational Study
6%
Carbidopa Plus Levodopa
6%
Dabigatran
6%
Siponimod
6%
Ofatumumab
6%
Brain Hematoma
6%
Troponin T
6%
Gadolinium
6%
Syndrome
6%
Parkinson's Disease
6%
Cross Sectional Study
6%
Ankylosing Spondylitis
6%
Clinical Feature
6%
Tenecteplase
6%
Human Herpesvirus 6
6%
Heart Left Ventricle Hypertrophy
6%
Octanoic Acid
6%
Automutilation
6%
Prevalence
6%
Daytime Somnolence
6%
Somnolence
6%
Sleep Disorder
6%
Lipopolysaccharide Binding Protein
6%
Polyradiculoneuropathy
6%
Anti N Methyl D Aspartate Receptor Encephalitis
6%
